Boer Shan

543 total citations
36 papers, 358 citations indexed

About

Boer Shan is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Boer Shan has authored 36 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Reproductive Medicine, 15 papers in Oncology and 11 papers in Obstetrics and Gynecology. Recurrent topics in Boer Shan's work include Ovarian cancer diagnosis and treatment (20 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Cancer Genomics and Diagnostics (6 papers). Boer Shan is often cited by papers focused on Ovarian cancer diagnosis and treatment (20 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Cancer Genomics and Diagnostics (6 papers). Boer Shan collaborates with scholars based in China, Switzerland and France. Boer Shan's co-authors include Huaying Wang, Yu Ren, Wenjuan Tian, Shuang Ye, Huijuan Yang, Shuling Zhou, Ying Gao, Daren Shi, Shanhui Liang and Qiongjie Zhou and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Boer Shan

31 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boer Shan China 12 149 145 105 84 81 36 358
Ting‐Tai Yen United States 10 140 0.9× 165 1.1× 87 0.8× 127 1.5× 172 2.1× 17 433
Tomoko Kurita Japan 12 106 0.7× 139 1.0× 94 0.9× 44 0.5× 117 1.4× 50 359
Mitsutake Yano Japan 13 152 1.0× 148 1.0× 154 1.5× 91 1.1× 174 2.1× 54 455
Gonghua Qi China 10 91 0.6× 105 0.7× 102 1.0× 73 0.9× 157 1.9× 16 365
Giuseppa Maltese Italy 11 215 1.4× 203 1.4× 115 1.1× 43 0.5× 65 0.8× 25 394
Daisuke Shintani Japan 10 129 0.9× 77 0.5× 82 0.8× 76 0.9× 84 1.0× 34 293
Shujie Pang China 8 114 0.8× 64 0.4× 52 0.5× 60 0.7× 89 1.1× 22 282
Daron Street United States 8 71 0.5× 88 0.6× 88 0.8× 35 0.4× 68 0.8× 11 271
Vanessa Costa Miranda Brazil 6 74 0.5× 69 0.5× 147 1.4× 48 0.6× 136 1.7× 11 298
S.F. Yim Hong Kong 11 110 0.7× 136 0.9× 97 0.9× 176 2.1× 268 3.3× 19 519

Countries citing papers authored by Boer Shan

Since Specialization
Citations

This map shows the geographic impact of Boer Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boer Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boer Shan more than expected).

Fields of papers citing papers by Boer Shan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boer Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boer Shan. The network helps show where Boer Shan may publish in the future.

Co-authorship network of co-authors of Boer Shan

This figure shows the co-authorship network connecting the top 25 collaborators of Boer Shan. A scholar is included among the top collaborators of Boer Shan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boer Shan. Boer Shan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Shuang, Yi Fu, Jun Wang, et al.. (2025). Surufatinib Combined With Toripalimab For The Treatment Of Recurrent Ovarian Clear Cell Carcinoma: Update Of A Prospective Single Center, Single-Arm Phase II Clinical Trial. International Journal of Gynecological Cancer. 35(2). 101019–101019.
2.
3.
4.
5.
Jiang, Wei, Chunjuan Jiang, Qianlan Yao, et al.. (2023). A NOTCH1 Mutation Found in a Newly Established Ovarian Cancer Cell Line (FDOVL) Promotes Lymph Node Metastasis in Ovarian Cancer. International Journal of Molecular Sciences. 24(6). 5091–5091. 4 indexed citations
6.
Shen, Wenbin, Chuyu Jing, Wenjuan Tian, et al.. (2023). Anlotinib in patients with recurrent platinum resistant/refractory ovarian cancer: a prospective, single arm, phase II study. International Journal of Gynecological Cancer. 33(11). 1764–1770. 5 indexed citations
7.
Ye, Shuang, Shuling Zhou, Boer Shan, et al.. (2022). The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma. BMC Cancer. 22(1). 449–449. 4 indexed citations
8.
Ye, Shuang, Qin Li, Yutuan Wu, et al.. (2022). Integrative genomic and transcriptomic analysis reveals immune subtypes and prognostic markers in ovarian clear cell carcinoma. British Journal of Cancer. 126(8). 1215–1223. 19 indexed citations
9.
Chen, Wei, Boer Shan, Shuling Zhou, Huijuan Yang, & Shuang Ye. (2022). Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma. BMC Cancer. 22(1). 92–92. 12 indexed citations
10.
Tian, Wenjuan, Jingshu Wang, Rui Bi, et al.. (2022). Characterization of hotspot exonuclease domain mutations in the DNA polymerase ϵ gene in endometrial cancer. Frontiers in Oncology. 12. 1018034–1018034. 11 indexed citations
11.
12.
Shen, Wenbin, Boer Shan, Shanhui Liang, et al.. (2021). Hybrid Capture-based Genomic Profiling of Circulating Tumor DNA From Patients With Advanced Ovarian Cancer. Pathology & Oncology Research. 27. 581534–581534. 7 indexed citations
13.
Li, Pu, Yuezong Bai, Boer Shan, et al.. (2021). Exploration of Potential Diagnostic Value of Protein Content in Serum Small Extracellular Vesicles for Early-Stage Epithelial Ovarian Carcinoma. Frontiers in Oncology. 11. 707658–707658. 12 indexed citations
14.
Cheng, Yuan, Yangyang Dong, Wenjuan Tian, et al.. (2020). Nomogram for Predicting Recurrence-Free Survival in Chinese Women with Endometrial Cancer after Initial Therapy: External Validation. Journal of Oncology. 2020. 1–11. 5 indexed citations
15.
Shan, Boer, Fan Hu, Ying Xiao, et al.. (2020). Plasma omega-3 polyunsaturated fatty acids and recurrence of endometrial cancer. BMC Cancer. 20(1). 576–576. 6 indexed citations
16.
Chen, Wei, Boer Shan, Shuling Zhou, et al.. (2020). Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications. Journal of Ovarian Research. 13(1). 89–89. 22 indexed citations
17.
Xie, Li, Ruimin Li, Boer Shan, et al.. (2020). A preoperative prediction model for predicting coexisting adnexa malignancy of patients with G1/G2 endometrioid endometrial cancer. Gynecologic Oncology. 159(2). 402–408. 8 indexed citations
18.
Li, Yao, et al.. (2016). Construction and functional analysis of an anti-human cervical carcinoma/anti-human CD3 single-chain bispecific antibody. Molecular Medicine Reports. 14(1). 804–810. 2 indexed citations
19.
Sun, Xin, et al.. (2016). Detection of circulating tumour cells may add value in endometrial cancer management. European Journal of Obstetrics & Gynecology and Reproductive Biology. 207. 1–4. 18 indexed citations
20.
Ren, Yu, Xiaowei Huang, Boer Shan, et al.. (2015). Adjuvant concurrent chemoradiation followed by chemotherapy for high-risk endometrial cancer. Gynecologic Oncology. 140(1). 58–63. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ting‐Tai Yen Breakdown of academic impact, for papers by Tomoko Kurita Breakdown of academic impact, for papers by Mitsutake Yano Breakdown of academic impact, for papers by Gonghua Qi Breakdown of academic impact, for papers by Giuseppa Maltese Breakdown of academic impact, for papers by Daisuke Shintani Breakdown of academic impact, for papers by Shujie Pang Breakdown of academic impact, for papers by Daron Street Breakdown of academic impact, for papers by Vanessa Costa Miranda Breakdown of academic impact, for papers by S.F. Yim
Rankless by CCL
2026